Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043988
Filing Date
2021-08-12
Accepted
2021-08-12 16:16:35
Documents
42
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20210630.htm   iXBRL 10-Q 1154186
2 EX-31.1 mnov-ex311_7.htm EX-31.1 10997
3 EX-31.2 mnov-ex312_9.htm EX-31.2 11009
4 EX-32.1 mnov-ex321_8.htm EX-32.1 7897
5 EX-32.2 mnov-ex322_6.htm EX-32.2 7885
  Complete submission text file 0001564590-21-043988.txt   3407228

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnov-20210630.xsd EX-101.SCH 24680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20210630_cal.xml EX-101.CAL 23226
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20210630_def.xml EX-101.DEF 70322
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20210630_lab.xml EX-101.LAB 225213
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20210630_pre.xml EX-101.PRE 162055
11 EXTRACTED XBRL INSTANCE DOCUMENT mnov-10q_20210630_htm.xml XML 377614
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 211167786
SIC: 2834 Pharmaceutical Preparations